L Catterton and Altas Partners have agreed to acquire a majority stake in Fullscript from HGGC and Snapdragon Capital Partners, backing the healthcare technology company’s next phase of expansion. Financial terms of the transaction were not disclosed.
Fullscript provides an integrated platform designed for healthcare practitioners delivering whole-person care, bringing together data, diagnostic resources and other clinical tools.
More than 135,000 healthcare practitioners currently use Fullscript to support approximately 10 million patients annually across North America.
The platform includes practitioner-directed supplement recommendations and fulfillment, laboratory management, wearable health data integration and tools focused on patient adherence and outcomes.
The new investment is intended to support expansion of Fullscript’s platform and clinical support capabilities while increasing its reach across the North American healthcare market.
Fullscript was founded in 2011.
The company has recently expanded the breadth of its platform through product development, partnerships and acquisitions.
University Hospitals recently became a major health system to integrate Fullscript into its Epic workflow, allowing providers to recommend clinician-grade supplements directly through the electronic health record.
Fullscript launched Fullscript Journeys in April 2026 to help providers deliver more personalized health experiences while maintaining clinical guidance.
In January 2026, Fullscript partnered with Oura to bring wearable biometric data into clinical workflows alongside lab results and patient treatment histories.
The company also acquired Rupa Health in 2024, adding laboratory ordering and management capabilities.
The transaction is expected to close in the fourth quarter of 2026, subject to regulatory approvals and customary closing conditions.
Centerview Partners is serving as financial advisor to Fullscript.
Evercore, Morgan Stanley and RBC Capital Markets are serving as financial advisors to Altas and L Catterton, while McDermott Will & Emery and Kirkland & Ellis are serving as their legal counsel.
Jefferies and William Blair are serving as financial advisors to HGGC and Snapdragon.
KEY QUOTES:
“Practitioners are at the core of our business. We have built Fullscript around a simple belief: they should have the tools and information needed to see the whole patient and deliver better care. That belief will continue to guide how we grow. Altas and L Catterton share our conviction in where healthcare is headed, and their investment and experience will help us accelerate that vision.”
Kyle Braatz, CEO and Co-Founder of Fullscript
“The convergence of conventional and functional medicine is happening at a rapid pace. Millions of Americans are seeking trusted sources of education and treatment solutions to manage chronic conditions and prevent disease in order to live their healthiest life. Practitioners require a platform that can provide trusted whole-health protocols and products that is integrated into their daily practice management and assures safety and efficacy. Fullscript does just that.”
Marc Magliacano, Managing Partner at L Catterton
“Fullscript has established itself as a clear leader in whole-person care, with an exceptional management team and a differentiated model that position the company for significant continued growth. We have spent considerable time studying this market and have been particularly impressed by the strength of Fullscript’s platform, the trust it has earned from practitioners, and the critical role it plays in helping them care for their patients.”
Paul Emery, Partner at Altas Partners
